Compare LTBR & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTBR | OFIX |
|---|---|---|
| Founded | 1992 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.6M | 473.3M |
| IPO Year | 2015 | 1998 |
| Metric | LTBR | OFIX |
|---|---|---|
| Price | $12.32 | $11.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | ★ 745.4K | 208.0K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $8.85 | $10.25 |
| 52 Week High | $31.34 | $16.99 |
| Indicator | LTBR | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 38.68 |
| Support Level | $11.00 | $10.94 |
| Resistance Level | $14.10 | $16.38 |
| Average True Range (ATR) | 0.97 | 0.46 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 49.20 | 8.23 |
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.